PATENT CLAIM ANALYSIS

Application Number: 15961726
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "178000"]

Abstract:
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone C max  to serum testosterone C ave  of about 2.7 or less. In yet another embodiment, a method for providing a serum concentration of testosterone within a target serum testosterone concentration C ave  range for a male subject is provided.

Claim (Index 6):
The method of  claim 1 , wherein in said carrier comprises a fatty acid, a triglyceride and a hydrophilic surfactant.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.90789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14691229', '15485154', '14952796', '15955429', '15818697']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8592146429955367
- 35 USC 102 Novelty (BERT): 0.6282134131026371
- Combined Prediction Score: 0.8361145200062469
- Mean Citation Score: 552.595292
- Max Citation Score: 571.5115
- Similarity Product: 467.20369931787246

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test